Kearney, Patrick J. http://orcid.org/0000-0002-7145-5964
Zhang, Yuanxi
Liang, Marianna http://orcid.org/0000-0001-6702-3256
Tan, Yanglan
Kahuno, Elizabeth http://orcid.org/0000-0003-0170-3237
Conklin, Tucker L.
Fagan, Rita R. http://orcid.org/0000-0002-8600-0364
Pavchinskiy, Rebecca G.
Shaffer, Scott A. http://orcid.org/0000-0002-5264-3257
Yue, Zhenyu http://orcid.org/0000-0001-8730-8515
Melikian, Haley E. http://orcid.org/0000-0002-9694-5556
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA035224, 1F31DA045446)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (P20NS123220, R21NS109895)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Parkinson’s Disease Foundation (PF-RC-936279)
U.S. Department of Health & Human Services | National Institutes of Health (5T32AG49688-9)
Article History
Received: 16 May 2023
Accepted: 30 January 2024
First Online: 23 February 2024
Competing interests
: The authors declare no competing interests.